Huachuma, the Andean cactus better known as San Pedro, contains mescaline, a psychoactive compound that alters perception and mood.
Articles on Ayahuasca
Displaying all articles
Magic mushrooms and LSD may do more than bend minds: they could fight inflammation linked to depression, arthritis and heart disease.
Several religious groups have historically used psychedelics for healing. Now, a growing number are pushing for their use as a way to mystical experiences.
The psychotropic allure of the ayahuasca plant for hundreds of thousands of non-Indigenous consciousness seekers is raising many concerns.
One in seven Canadian veterans is living with PTSD. Developing a psychedelics research program for veterans should be a public health priority.
Change in the brain usually comes with plenty of effort over time. Neuroscientists are working to understand how psychedelic drugs provide a shortcut that seems to rely on existing brain systems.
An anthropology course explores how peoples and cultures around the world use nature-based medicines to heal.
The early research suggests the drugs might be effective for some conditions. But scientists have safety concerns.
Many studies have looked at the potential benefits of ayahuasca, but few have analysed its side-effects.
Once associated with mind-control experiments and counter-cultural defiance, psychedelics now show great promise for mental health treatments and may prompt a re-evaluation of the scientific method.
Ayahuasca has long been used for indigenous healing and spiritual rituals. Now, a Brazilian clinical trial has confirmed that this psychoactive drink can help those with even severe depression.
Western science is “discovering” the medical potential of ayahuasca, which Amazonian indigenous groups have used ritualistically for centuries.
Indigenous groups, religious movements and spiritual tourists use the psychoactive substance to communicate with forces and purge the soul.
A recent Norwegian study on psychedelic drugs and psychological well-being not only highlighted fewer mental health issues among users of these drugs but also underscored the reinvigoration of scientific…
Top contributors
-
Director, Executive Leadership Academy, University of California, Berkeley
-
Professor and Canada Research Chair in the History of Health & Social Justice, University of Saskatchewan
-
Universidade Federal do Rio Grande do Norte (UFRN)
-
Professor of Psychiatry, Universidade Estadual de Campinas (Unicamp)
-
Senior Lecturer of Addiction, Edith Cowan University
-
Research fellow, Swinburne University of Technology
-
Professor, Brain Institute, Universidade Federal do Rio Grande do Norte (UFRN)
-
Postdoctoral Fellow, Ribeirão Preto Medical School, Universidade de São Paulo (USP)
-
Affiliate Associate Professor of Psychiatry & Family Medicine, Medical University of South Carolina
-
Professor of Neuropharmacology, University of Lancashire
-
Professor of Neurology, University of California, San Francisco
-
Professor of Anthropology, Western Illinois University
-
Research Scientist, Queen's Health Sciences and Assistant Professor, Department of Psychiatry, Queen's University, Ontario
-
Professor, Translational Pharmacology, University of Birmingham
-
Professor of Modern Religion, Lancaster University